Back
Squarespace Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
52
SQSP
Squarespace
Last Price:
43.66
Seasonality Move:
-12.74%
Buy
51
ALNY
Alnylam Pharmaceuticals
Last Price:
242.97
Seasonality Move:
20.36%
Buy
52
Squarespace (SQSP)
is a Buy
Is Squarespace a Buy, Sell or Hold?
- The current Squarespace [SQSP] share price is $43.63. The Score for SQSP is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- SQSP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
51
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $243.08. The Score for ALNY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SQSP Stock Price Chart
What is Squarespace's stock price today?
-
The Squarespace share price today is $43.63
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SQSP is experiencing slight buying pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $243.08
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.
SQSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.56 | Buy |
Relative Strength Index (14 RSI): | 63.74 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.54 - 43.84) | Sell |
Bollinger Bands (100): | (32.75 - 42.11) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 22.91 | Buy |
Relative Strength Index (14 RSI): | 86.77 | Buy |
Chaikin Money Flow: | -1210062 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (135.8 - 205.74) | Buy |
Bollinger Bands (100): | (136.44 - 176.64) | Buy |
SQSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.6 | Buy |
20-day SMA: | 43.72 | Sell |
50-day SMA: | 40.95 | Buy |
200-day SMA: | 33.62 | Buy |
8-day EMA: | 43.6 | Buy |
20-day EMA: | 43.37 | Buy |
50-day EMA: | 41.37 | Buy |
200-day EMA: | 35.28 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 209.44 | Buy |
20-day SMA: | 176.25 | Buy |
50-day SMA: | 159.62 | Buy |
200-day SMA: | 165.96 | Buy |
8-day EMA: | 218.01 | Buy |
20-day EMA: | 188.75 | Buy |
50-day EMA: | 168.9 | Buy |
200-day EMA: | 168.09 | Buy |
Squarespace Earnings Growth & SQSP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.13 per share, an increase this year of $0.47 per share, and an increase next year of $0.34 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.46 per share, and an increase next year of $1.83 per share.
Squarespace Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |